title: [The council for new therapies position on eculizumab is unacceptable].
authors.forename: Diana
authors.initials: D
authors.lastname: Karpman
authors.forename: Ingela
authors.initials: I
authors.lastname: Fehrman-Ekholm
authors.forename: Peter
authors.initials: P
authors.lastname: Bárány
authors.forename: Zivile
authors.initials: Z
authors.lastname: Békássy
authors.forename: Per
authors.initials: P
authors.lastname: Brandström
authors.forename: Annette
authors.initials: A
authors.lastname: Bruchfeld
authors.forename: Gianni
authors.initials: G
authors.lastname: Celsi
authors.forename: Milan
authors.initials: M
authors.lastname: Chromek
authors.forename: Naomi
authors.initials: N
authors.lastname: Clyne
authors.forename: Bengt
authors.initials: B
authors.lastname: Fellström
authors.forename: Sverker
authors.initials: S
authors.lastname: Hansson
authors.forename: Börje
authors.initials: B
authors.lastname: Haraldsson
authors.forename: Tryggve
authors.initials: T
authors.lastname: Nevéus
authors.forename: Bengt
authors.initials: B
authors.lastname: Rippe
authors.forename: Lisa
authors.initials: L
authors.lastname: Sartz
authors.forename: Mårten
authors.initials: M
authors.lastname: Segelmark
authors.forename: Bernd
authors.initials: B
authors.lastname: Stegmayr
authors.forename: Peter
authors.initials: P
authors.lastname: Stenvinkel
authors.forename: Gunnar
authors.initials: G
authors.lastname: Tufveson
authors.forename: Kerstin
authors.initials: K
authors.lastname: Westman
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000191:economics / Q000627:therapeutic use; D065766:Atypical Hemolytic Uremic Syndrome / Q000188:drug therapy*; D002648:Child; D006801:Humans; D017410:Practice Guidelines as Topic / Q000592:standards*; D013548:Sweden
chemical_list: D061067:Antibodies, Monoclonal, Humanized; C481642:eculizumab